Bettina S. Nedergaard

Author

Also Known As

B Nedergaard, B S Nedergaard, B. S. Nedergaard, B.S. Nedergaard, BETTINA S. NEDERGAARD, Bettina Nedergaard, Bettina S Nedergaard, Bettina S. Nedergaard, Bettina Storgaard Nedergaard, Nedergaard, Bettina

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Center for Clinical & Basic Research Aarhus University Hospital Aalborg University Hospital Amgen (United States)University of Iowa

About

Bettina S. Nedergaard is an author at Center for Clinical & Basic Research specializing in medicine, orthopaedics, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	349
2	Public Health	1	1	15
3	Endocrinology	1	1	53
4	Epidemiology	1	1	15
5	Immunology	1	1	117

Bettina S. Nedergaard

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia Jennifer G. Robinson, Bettina S. Nedergaard, William J. Rogers, JAMA	2014	492
Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates Paul D. Miller, Nicola Pannacciulli, Jacques P. Brown, The Journal of Clinical Endocrinology & Metabolism	2016	230
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos, The Lancet Diabetes & Endocrinology Bone DiseaseOsteopathyLoft Extension StudyMedicineGynecology	2019	164
Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer Andreas Carus, Morten Ladekarl, Henrik Hager, British Journal of Cancer	2013	131
A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years Bettina S. Nedergaard, Morten Ladekarl, Jens Randel Nyengaard, Gynecologic Oncology Cancer ImmunosurveillanceCervical CancerMedicineSeveral ImmuneImmunology	2007	117
Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer Bettina S. Nedergaard, Morten Ladekarl, Henrik F. Thomsen, British Journal of Cancer	2007	87
A randomized, double-blinded, placebo-controlled, parallel trial of vitamin D<sub>3</sub> supplementation in adult patients with migraine Parisa Gazerani, Rasmus Fuglsang, J. G. A. Pedersen, Current Medical Research and Opinion	2018	68
Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1–31)NH2] in postmenopausal women with osteoporosis Kim Henriksen, J.R. Andersen, B.J. Riis, Bone Pharmacokinetic ProfileMedicineParathyroid HormoneGynecologyMenopause	2012	53
Rationale and Design of <scp>LAPLACE</scp>‐2: A Phase 3, Randomized, Double‐Blind, Placebo‐ and Ezetimibe‐Controlled Trial Evaluating the Efficacy and Safety of Evolocumab in Subjects With Hypercholesterolemia on Background Statin Therapy Jennifer G. Robinson, William J. Rogers, Bettina S. Nedergaard, Clinical Cardiology HyperlipidemiaPharmacotherapyEzetimibe‐controlled TrialThrombosisTranslational Medicine	2014	15
Stereologic estimation of the total numbers, the composition and the anatomic distribution of lymphocytes in cone biopsies from patients with stage I squamous cell carcinoma of the cervix uteri Bettina S. Nedergaard, Karsten Nielsen, Jens Randel Nyengaard, Apmis	2007	12

Page 1